Have a personal or library account? Click to login
Left Atrial Volume Quantified by MSCT Predicts Emergency Hospitalizations for AF and Arrhythmia Recurrence after Catheter Ablation Cover

Left Atrial Volume Quantified by MSCT Predicts Emergency Hospitalizations for AF and Arrhythmia Recurrence after Catheter Ablation

Open Access
|Jun 2023

References

  1. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of AF: the Task Force for the Management of AF of the European Society of Cardiology (ESC). Eur Heart J. 2010;31:2369–2429. doi: 10.1093/eurheartj/ehq278.
  2. de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent AF clinical correlates and prognosis. J Am Coll Cardiol. 2010;55:725–731. doi: 10.1016/j. jacc.2009.11.040.
  3. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of AF developed in collaboration with EACTS. Eur Heart J. 2016;50:5:e1–e88. doi: 10.1093/ejcts/ezw313.
  4. Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic AF: the Framingham Heart Study. Circulation. 1994;89:724–730. doi: 10.1161/01.cir.89.2.724.
  5. Takemoto Y, Barnes ME, Seward JB, et al. Usefulness of left atrial volume in predicting first congestive heart failure in patients ≥65 years of age with well-preserved left ventricular systolic function. Am J Cardiol. 2005;96:832–836. doi: 10.1016/j.amjcard.2005.05.031.
  6. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835–841.
  7. Su G, Cao H, Xu S, et al. Left Atrial Enlargement in the Early Stage of Hypertensive Heart Disease: A Common But Ignored Condition. The Journal of Clinical Hypertension. 2014;16:3:192-197. doi: 10.1111/jch.12282.
  8. Guglielmo M, Baggiano A, Muscogiuri G, et al. Multimodality imaging of left atrium in patients with AF. Journal of Cardiovascular Computed Tomography. 2019;6:340-346. doi: 10.1016/j.jcct.2019.03.005.
  9. Mahabadi AA, Samy B, Seneviratne SK, et al. Quantitative assessment of left atrial volume by electrocardiographic-gated contrast-enhanced multidetector computed tomography. J Cardiovasc Comput Tomogr. 2009;3:80–87. doi: 10.1016/j. jcct.2009.02.002.
  10. Christiaens L, Lequeux B, Ardilouze P, et al. A new method for measurement of left atrial volumes using 64-slice spiral computed tomography: comparison with two-dimensional echocardiographic techniques. Int J Cardiol. 2009;131:217–224. doi: 10.1016/j.ijcard.2007.10.020.
  11. Avelar E, Durst R, Rosito GA, et al. Comparison of the accuracy of multidetector computed tomography versus two-dimensional echocardiography to measure left atrial volume. Am J Cardiol. 2010;106:104–109. doi: 10.1016/j.amjcard.2010.02.021.
  12. Blum S, Meyre P, Aeschbacher S, Berger S, et al. Incidence and Predictors of AF Progression: A Systematic Review and Meta-Analysis. Heart Rhythm. 2018;16:4:502–510. doi: 10.1016/j. hrthm.2018.10.022.
  13. Nicolaou VN, Papadakis JE, Karatzis EN, et al. Impact of the metabolic syndrome on atrial size in patients with new-onset AF. Angiology. 2007;58:21–25. doi: 10.1177/0003319706297913.
  14. Ayer JG, Almafragy HS, Patel AA, et al. Body mass index is an independent determinant of left atrial size. Heart Lung Circ. 2008;17:19–24. doi: 10.1016/j.hlc.2007.04.006.
  15. Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30:2019–2024. doi: 10.1161/01. str.30.10.2019.
  16. Lemire F, Tajik AJ, Hagler DJ. Asymmetric left atrial enlargement; an echocardiographic observation. Chest. 1976;69:779–781. doi: 10.1378/chest.69.6.779.
  17. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol. 1999;84:829–832. doi: 10.1016/s0002-9149(99)00446-4.
  18. Russo C, Jin Z, Homma S, et al. Left atrial minimum volume and reservoir function as correlates of left ventricular diastolic function: impact of left ventricular systolic function. Heart. 2012;98:813–820. doi: 10.1136/heartjnl-2011-301388.
  19. Lee JS, Shim CY, Wi J, et al. Left ventricular diastolic function is closely associated with mechanical function of the left atrium in patients with paroxysmal AF. Circ J. 2013;77:697–704. doi: 10.1253/circj.cj-12-1009.
  20. Park SM, Park SW, Casaclang-Verzosa G, et al. Diastolic dysfunction and left atrial enlargement as contributing factors to functional mitral regurgitation in dilated cardiomyopathy data from the Acorn trial. Am Heart J. 2009;157:762–710. doi: 10.1016/j.ahj.2008.12.018.
  21. Cheng YJ, Church TS, Kimball TE, et al. Comparison of coronary artery calcium detected by electron beam tomography in patients with to those without symptomatic coronary heart disease. Am J Cardiol. 2003;92:498–503. doi: 10.1016/s0002-9149(03)00714-8.
  22. Dzeshka MS, Lip GY, Snezhitskiy V, Shantsila E. Cardiac fibrosis in patients with AF: mechanisms and clinical implications. J Am Coll Cardiol. 2015;66:943–959. doi: 10.1016/j.jacc.2015.06.1313.
  23. O’Neal WT, Efird JT, Qureshi WT, et al. Coronary artery calcium progression and AF: the multi-ethnic study of atherosclerosis. Circ Cardiovasc Imaging. 2015;8:e003786. doi: 10.1161/CIRCIMAGING.115.003786.
  24. Pan NH, Tsao HM, Chang NC, Lee CM, Chen YJ, Chen SA. Dilated left atrium and pulmonary veins in patients with calcified coronary artery: a potential contributor to the genesis of AF. J Cardiovasc Electrophysiol. 2009;20:153–158. doi: 10.1111/j.1540-8167.2008.01290.x.
  25. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during AF. Cardiovasc Res. 2002;54:230–246. doi: 10.1016/s0008-6363(02)00258-4.
  26. Avitall B, Bi J, Mykytsey A, Chicos A. Atrial and ventricular fibrosis induced by AF: evidence to support early rhythm control. Heart Rhythm. 2008;5:839–845. doi: 10.1016/j. hrthm.2008.02.042.
  27. Hu YF, Chen YJ, Lin YJ, Chen SA. Inflammation and the pathogenesis of AF. Nat Rev Cardiol. 2015;12:230–243. doi: 10.1038/nrcardio.2015.2.
  28. O’Neill MD, Jaïs P, Takahashi Y, et al. The stepwise ablation approach for chronic AF--evidence for a cumulative effect. J Interv Card Electrophysiol. 2006;16:153–167. doi: 10.1007/s10840-006-9045-1.
  29. Blîndu E, Korodi S, Bordi L, Kovács I, Benedek I. Epicardial Fat Volume as a New Imaging-Based Feature Associated with Risk of Recurrence after Pulmonary Veins Ablation in AF. Journal of Interdisciplinary Medicine. 2020;5:2:64–70. doi: 10.2478/jim-2020-0012.
  30. Waldo AL, Becker RC, Tapson VF, Colgan KJ. Hospitalized patients with AF and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol. 2005;46:1729–1736. doi: 10.1016/j.jacc.2005.06.077.
  31. Andersson T, Magnuson A, Bryngelsson IL, et al. All-cause mortality in 272,186 patients hospitalized with incident AF 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J. 2013;34:1061–1067. doi: 10.1093/eurheartj/ehs469.
  32. Chen SC, Chang JM, Tsai YC, et al. Left atrial diameter and albumin with renal outcomes in chronic kidney disease. Int J Med Sci. 2013;10:575–584. doi: 10.7150/ijms.5845.
  33. Santhanakrishnan R, Wang N, Larson MG, et al. AF begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133:484–492. doi: 10.1161/CIRCULATIONAHA.115.018614.
  34. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal AF: the APAF study. J Am Coll Cardiol. 2006;48:2340–2347. doi: 10.1016/j. jacc.2006.08.037.
  35. Jaïs P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for AF: the A4 study. Circulation. 2008;118:2498–2505. doi: 10.1161/CIRCULATIONAHA.108.772582.
  36. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal AF: a randomized controlled trial. JAMA. 2010;303:333–340. doi: 10.1001/jama.2009.2029.
  37. Marrouche NF, Brachmann J, Andresen D, Siebels et al. CASTLE-AF Investigators. Catheter ablation for AF with heart failure. N Engl J Med. 2018;378:417–427. doi: 10.1056/NEJMoa1707855.
  38. Jones DG, Haldar SK, Hussain W, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent AF in heart failure. J Am Coll Cardiol. 2013;61:1894–1903. doi: 10.1016/j.jacc.2013.01.069.
  39. Hunter RJ, Berriman TJ, Diab I, et al. A randomized controlled trial of catheter ablation versus medical treatment of AF in heart failure (the CAMTAF trial). Circ Arrhythm Electrophysiol. 2014;7:31–38. doi: 10.1161/CIRCEP.113.000806.
  40. Siontis KC, Noseworthy PA. FIRE or ICE for paroxysmal AF?—perspectives from the largest randomized evaluation of cryoballoon and radiofrequency ablation to date. J Thorac Dis. 2017;9:3:419-422. doi: 10.21037/jtd.2017.02.93.
DOI: https://doi.org/10.2478/jce-2023-0004 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 24 - 31
Submitted on: Apr 6, 2023
|
Accepted on: Apr 28, 2023
|
Published on: Jun 30, 2023
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 László-Lehel Bordi, Diana Opincariu, Theodora Benedek, István Kovács, Zsolt Parajkó, Emese Márton, Renáta Gerculy, Imre Benedek, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.